Everolimus-eluting stents are largely used for left main (LM) percutaneous coronary interventions (PCI). Long-term follow-up of patients who underwent LM PCI in a real world clinical setting, in particular women, have been scarcely reported. Consecutive patients who underwent unprotected LM PCI with EES at a single Institution from December 2006 to April 2016 were included. Main outcome assessed was the occurrence of major adverse cardiovascular events (MACE) as a composite of death, myocardial infarction or target lesion revascularization at follow-up.
Trabattoni D, Teruzzi G, Montorsi P, Fabbiocchi F, Gili S, Calligaris G, Grancini L, Galli S, Ravagnani P, Bartorelli A. Comparison of the Effectiveness of Percutaneous Intervention of the Left-Main Coronary Artery With Everolimus-Eluting Stents in Women -Vs- Men. Am J Cardiol 2019 Aug 16. pii: S0002-9149(19)30891-4. doi: 10.1016/j.amjcard.2019.07.060